Malaysia Exempts Low-Risk Devices From Conformity Assessment, But Registration Mandatory
This article was originally published in SRA
Executive Summary
The Malaysian government exempted all types of Class A (lowest-risk) devices from conformity assessment requirements as of April 18 to make it easier for companies to bring such products to the market1. These devices, however, will have to continue complying with other regulatory requirements such as labelling and post-marketing commitments.
You may also be interested in...
Malaysian Medtech Agency Introduces New Fee To Tackle Surge In Product Classification Enquiries
The Malaysian medtech regulator says an increase in product classification-related enquiries is causing a drain on its resources and the service should be supported by a fee.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.